The treatment of restless legs syndrome

Neurological Sciences

Volumn 28, Issue SUPL.1, 2007, Pages

  Montagna, Pasquale ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dopaminergic agents; Guidelines; Levodopa; Restless legs syndrome; Therapy; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENSERAZIDE PLUS LEVODOPA; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CABERGOLINE; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; FERROUS SULFATE; GABAPENTIN; HYPNOTIC AGENT; IRON DEXTRAN; LEVODOPA; OXYCODONE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; TRAMADOL; VITAMIN;

APATHY; CLINICAL TRIAL; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG WITHDRAWAL; DYSPEPSIA; HUMAN; LUNG FIBROSIS; MEMORY DISORDER; MENTAL DISEASE; MUSCLE WEAKNESS; NAUSEA; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; QUALITY OF LIFE; RESPIRATORY FAILURE; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SENSORY DYSFUNCTION; SHORT COURSE THERAPY; SIDE EFFECT; SOMNOLENCE; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VERTIGO; VIBRATION; VITAMIN SUPPLEMENTATION; XEROSTOMIA;

EID: 33846487256     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0739-7     Document Type: Review

References (41)

1. Willis T (1685) The London practice of physic. Bassett and Crooke, London, UK
2. Wittmaack T (1861) Pathologie und Therapie der Sensibilitatneurosen. E. Schafer, Leipzig, Deutschland, pp 459
3. Oppenheim H (1923) Lehrbuch der Nervenkrakheiten. Karger, Berlin, Deutschland, pp 1774
4. Ekbom KA (1944) Asthenia crurum paraesthetica ('Irritable legs'). New syndrome consisting of weakness, sensation of cold and nocturnal paresthesia in legs, responding to certain extent to treatment with Priscol and Doryl; note on paresthesia in general. Acta Med Scand 118:197-209
5. Ekbom KA (1945) Restless legs: Clinical study of hitherto overlooked disease in legs characterized by peculiar paresthesia ('Anxietas tibiarum'), pain and weakness and occurring in two main forms, asthenia crurum paraesthetica and asthenia crurum dolorosa; short review of paresthesias in general. Acta Med Scand 158:1-123
6. Lugaresi E, Tassinari CA, Coccagna G et al (1965) Particularites cliniques et polygraphiques du syndrome d'impatience des membres inferieurs. Rev Neurol (Paris) 113:545-555
7. Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10:634-642
8. Allen RP, Picchietti D, Hening WA et al (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101-119
9. The International Restless Legs Syndrome Study Group (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs. Sleep Med 4:121-132
10. Atkinson MJ, Allen RP, DuChane J et al (2004) Validation of the Restless Legs Syndrome Quality of Life Instrument (RLSQLI): Findings of a consortium of national experts and the RLS Foundation. Qual Life Res 13:679-693
11. Akpinar S (1982) Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 39:739
12. Cervenka S, Palhagen SE, Comley RA et al (2006) Support for dopaminergic hypoactivity in restless legs syndrome: A PET study on D2-receptor binding. Brain 129:2017-2028
13. Allen RP, Earley CJ (2001) Restless Legs Syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol 18:128-147
14. Trenkwalder C, Paulus W,Walters AS (2005) The restless legs syndrome. Lancet Neurol 4:465-475
15. Hening WA, Allen R, Earley C et al (1999) The treatment of restless legs syndrome and periodic limb movement disorder - an American Academy of Sleep Medicine Review. Sleep 22:970-999
16. Hening WA, Allen RP, Earley CJ et al (2004) An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27:560-583
17. Chesson AL Jr, Wise M, Davila D et al (1999) Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 22:961-968
18. Vignatelli L, Billiard M, Clarenbach P et al (2006) EFNS Guidelines on Management of Restless Legs Syndrome and Periodic Limb Movement Disorder in Sleep. Eur J Neurol 13:1049-1065
19. Allen RP,Walters AS, Montplaisir J et al (2005) Restless legs syndrome prevalence and impact: REST general population study (RLS epidemiology, symptoms, and treatment). Arch Intern Med 165:1286-1292
20. Ulfberg J, Nystrom B, Carter N, Edling C (2001) Prevalence of Restless Legs Syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms. Mov Disord 16:1159-1163
21. Phillips B, Hening W, Britz P, Mannino D (2006) Prevalence and correlates of Restless Legs Syndrome: Results from the 2005 National Sleep Foundation Poll. Chest 129:76-80
22. Winkelmann J, Wetter TC, Collado-Seidel V et al (2000) Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23:597-602
23. Trenkwalder C, Seidel VC, Gasser T, Oertel WH (1996) Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 11:389-394
24. Montagna P, Coccagna G, Cirignotta F, Lugaresi E (1983) Familial RLS: long term follow-up. In: Guilleminault C, Lugaresi E (eds) Sleep/wake disorders: Natural history, epidemiology and long-term evolution. Raven Press, New York
25. Brainin M, Barnes M, Baron JC et al (2004) Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. Eur J Neurol 11:577-581
26. Wagner ML, Walters AS, Coleman RG et al (1996) Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 19:52-58
27. Garcia-Borreguero D, Larrosa O, de la Llave Y et al (2002) Treatment of restless legs syndrome with gabapentin: A double-blind, crossover study. Neurology 59:1573-1579
28. Montagna P, Sassoli-de-Bianchi L, Zucconi M et al (1984) Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 69:428-430
29. Walters AS, Wagner ML, Hening WA et al (1993) Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16:327-332
30. Benes H, Kurella B, Kummer J et al (1999) Rapid onset of action of levodopa in restless legs syndrome: A double-blind, randomized, multicenter, crossover trial. Sleep 22:1073-1081
31. Trenkwalder C, Hundemer HP, Lledo A et al (2004) Efficacy of pergolide in treatment of restless legs syndrome: The PEARLS Study. Neurology 62:1391-1397
32. Stiasny-Kolster K, Benes H, Peglau I et al (2004) Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 63:2272-2279
33. Partinen M, Hirvonen K, Jama L et al (2006) Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study - The PRELUDE study. Sleep Med 7:407-417
34. Winkelman JW, Sethi KD, Kushida CA et al (2006) Efficacy and safety of pramipexole in restless legs syndrome. Neurology 67:1034-1039
35. Trenkwalder C, Garcia-Borreguero D, Montagna P et al (2004) Ropinirole in the treatment of restless legs syndrome: Results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75:92-97
36. Walters AS, Ondo W, Dreykluft T et al (2004) Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallelgroup, placebo-controlled study. Mov Disord 19:1414-1423
37. Adler CH, Hauser RA, Sethi K et al (2004) Ropinirole for restless legs syndrome: A placebo-controlled crossover trial. Neurology 62:1405-1407
38. Bliwise DL, Freeman A, Ingram CD et al (2005) Randomized, double-blind placebo-controlled short term trial of ropinirole in restless legs syndrome. Sleep Med 6:141-147
39. Stiasny-Kolster K, Kohen R, Schollmayer E et al, Rotigotine Sp 666 Study Group (2004) Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double-blind, placebo-controlled pilot study. Mov Disord 19:1432-1438
40. Earley CJ, Heckler D, Allen RP (2004) The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5:231-235
41. Allen RP, Earley CJ (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19:205-213